Kathleen N Stern

Title: Innovations in Hemoglobin Therapy by Kathleen N Stern

Introduction

Kathleen N Stern is a notable inventor based in Lake Zurich, IL (US). She has made significant contributions to the field of medical therapies, particularly in hemodialysis. With a total of 2 patents, her work focuses on improving patient outcomes during critical medical procedures.

Latest Patents

One of her latest patents involves hemoglobin therapy in hemodialysis. In this innovative approach, low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis. This therapy aims to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Furthermore, when implemented prophylactically, hemoglobin therapy can partially obviate the need for further interventions to control circulatory system instability.

Career Highlights

Kathleen is associated with Baxter International Inc., a leading company in the healthcare sector. Her work at Baxter has allowed her to focus on groundbreaking research and development in medical therapies.

Collaborations

Throughout her career, Kathleen has collaborated with esteemed colleagues, including John D Blue and Jan W Garber. These collaborations have contributed to her innovative research and the advancement of medical therapies.

Conclusion

Kathleen N Stern's contributions to hemoglobin therapy in hemodialysis exemplify her commitment to improving patient care. Her innovative approaches and collaborations continue to influence the medical field positively.